Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Trillium Trading is a leading U.S.-based proprietary trading firm specializing in equities and algorithmic trading. Founded in 2003 and headquartered in New York City with additional offices in Miami and Chicago, the firm uses its own capital to trade financial instruments—primarily U.S. equities—rather than managing client funds. The company is known for its robust trader training programs, collaborative culture, advanced proprietary technology platforms built by an internal engineering team, and strong compliance record. It employs over 100 people including traders and support staff.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Trillium Trading.